Is InspireMD Stock a Good Investment?
InspireMD Investment Advice | NSPR |
- Examine InspireMD's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research InspireMD's leadership team and their track record. Good management can help InspireMD navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact InspireMD's business and its evolving consumer preferences.
- Compare InspireMD's performance and market position to its competitors. Analyze how InspireMD is positioned in terms of product offerings, innovation, and market share.
- Check if InspireMD pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about InspireMD's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in InspireMD stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if InspireMD is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Unstable | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine InspireMD Stock
Researching InspireMD's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 21.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.53. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. InspireMD recorded a loss per share of 0.71. The entity last dividend was issued on the 1st of April 2019. The firm had 1:15 split on the 27th of April 2021.
To determine if InspireMD is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding InspireMD's research are outlined below:
| InspireMD had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 6.21 M. Net Loss for the year was (19.92 M) with profit before overhead, payroll, taxes, and interest of 1.54 M. | |
| InspireMD currently holds about 26.47 M in cash with (16.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.18, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| InspireMD has a frail financial position based on the latest SEC disclosures | |
| Roughly 21.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Roubin Gary S of 11098 shares of InspireMD at 3.14 subject to Rule 16b-3 |
InspireMD Quarterly Cash And Short Term Investments |
|
InspireMD uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in InspireMD. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to InspireMD's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact InspireMD's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises InspireMD's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-05 | 2024-06-30 | -0.19 | -0.22 | -0.03 | 15 | ||
2024-03-05 | 2023-12-31 | -0.19 | -0.16 | 0.03 | 15 | ||
2024-11-04 | 2024-09-30 | -0.2 | -0.1631 | 0.0369 | 18 | ||
2024-05-13 | 2024-03-31 | -0.15 | -0.21 | -0.06 | 40 | ||
2023-08-07 | 2023-06-30 | -0.3 | -0.24 | 0.06 | 20 | ||
2021-05-10 | 2021-03-31 | -0.6 | -0.53 | 0.07 | 11 | ||
2022-08-08 | 2022-06-30 | -0.73 | -0.59 | 0.14 | 19 | ||
2023-05-15 | 2023-03-31 | -0.68 | -0.53 | 0.15 | 22 |
Know InspireMD's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as InspireMD is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading InspireMD backward and forwards among themselves. InspireMD's institutional investor refers to the entity that pools money to purchase InspireMD's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Mesirow Fin Investmt Mgmt Intl Equity | 2024-09-30 | 30 K | Elias Asset Management Inc | 2024-09-30 | 30 K | Northern Trust Corp | 2024-09-30 | 23.6 K | Hollencrest Securities, Llc | 2024-09-30 | 20 K | Geode Capital Management, Llc | 2024-09-30 | 18.2 K | Avestar Capital, Llc | 2024-09-30 | 15 K | Schonfeld Strategic Advisors Llc | 2024-09-30 | 11.9 K | Mckinley Carter Wealth Services Inc | 2024-12-31 | 10 K | Advisornet Financial, Inc | 2024-09-30 | 8.8 K | Rosalind Advisors, Inc. | 2024-09-30 | 2.5 M | Nantahala Capital Management, Llc | 2024-09-30 | 2.2 M |
InspireMD's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 67.04 M.Market Cap |
|
InspireMD's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.38) | (0.40) | |
| Return On Capital Employed | (0.58) | (0.61) | |
| Return On Assets | (0.38) | (0.40) | |
| Return On Equity | (0.58) | (0.55) |
Determining InspireMD's profitability involves analyzing its financial statements and using various financial metrics to determine if InspireMD is a good buy. For example, gross profit margin measures InspireMD's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of InspireMD's profitability and make more informed investment decisions.
InspireMD's Earnings Breakdown by Geography
Evaluate InspireMD's management efficiency
InspireMD has return on total asset (ROA) of (0.3724) % which means that it has lost $0.3724 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6675) %, meaning that it created substantial loss on money invested by shareholders. InspireMD's management efficiency ratios could be used to measure how well InspireMD manages its routine affairs as well as how well it operates its assets and liabilities. As of 01/31/2025, Return On Tangible Assets is likely to drop to -0.4. In addition to that, Return On Capital Employed is likely to drop to -0.61. At this time, InspireMD's Total Assets are relatively stable compared to the past year. As of 01/31/2025, Total Current Assets is likely to grow to about 53.3 M, while Other Assets are likely to drop slightly above 506 K.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.46 | 1.54 | |
| Tangible Book Value Per Share | 1.46 | 1.54 | |
| Enterprise Value Over EBITDA | (2.59) | (2.72) | |
| Price Book Value Ratio | 1.55 | 1.63 | |
| Enterprise Value Multiple | (2.59) | (2.72) | |
| Price Fair Value | 1.55 | 1.63 | |
| Enterprise Value | 54.1 M | 56.8 M |
Effective leadership at InspireMD drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Beta 0.928 |
Basic technical analysis of InspireMD Stock
As of the 31st of January, InspireMD retains the Risk Adjusted Performance of 0.0377, downside deviation of 3.35, and Market Risk Adjusted Performance of (2.97). Concerning fundamental indicators, the technical analysis model lets you check existing technical drivers of InspireMD, as well as the relationship between them. Please check out InspireMD information ratio and downside variance to decide if InspireMD is priced fairly, providing market reflects its last-minute price of 2.57 per share. Please also validate InspireMD total risk alpha, which is currently at (0.26) to confirm the company can sustain itself at a future point.InspireMD's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific InspireMD insiders, such as employees or executives, is commonly permitted as long as it does not rely on InspireMD's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases InspireMD insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
InspireMD's Outstanding Corporate Bonds
InspireMD issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. InspireMD uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most InspireMD bonds can be classified according to their maturity, which is the date when InspireMD has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Understand InspireMD's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing InspireMD's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0377 | |||
| Market Risk Adjusted Performance | (2.97) | |||
| Mean Deviation | 2.59 | |||
| Semi Deviation | 3.07 | |||
| Downside Deviation | 3.35 | |||
| Coefficient Of Variation | 2779.24 | |||
| Standard Deviation | 3.49 | |||
| Variance | 12.16 | |||
| Information Ratio | 0.0073 | |||
| Jensen Alpha | 0.1189 | |||
| Total Risk Alpha | (0.26) | |||
| Sortino Ratio | 0.0076 | |||
| Treynor Ratio | (2.98) | |||
| Maximum Drawdown | 17.26 | |||
| Value At Risk | (5.56) | |||
| Potential Upside | 6.74 | |||
| Downside Variance | 11.22 | |||
| Semi Variance | 9.44 | |||
| Expected Short fall | (2.88) | |||
| Skewness | 0.5539 | |||
| Kurtosis | 0.8366 |
| Risk Adjusted Performance | 0.0377 | |||
| Market Risk Adjusted Performance | (2.97) | |||
| Mean Deviation | 2.59 | |||
| Semi Deviation | 3.07 | |||
| Downside Deviation | 3.35 | |||
| Coefficient Of Variation | 2779.24 | |||
| Standard Deviation | 3.49 | |||
| Variance | 12.16 | |||
| Information Ratio | 0.0073 | |||
| Jensen Alpha | 0.1189 | |||
| Total Risk Alpha | (0.26) | |||
| Sortino Ratio | 0.0076 | |||
| Treynor Ratio | (2.98) | |||
| Maximum Drawdown | 17.26 | |||
| Value At Risk | (5.56) | |||
| Potential Upside | 6.74 | |||
| Downside Variance | 11.22 | |||
| Semi Variance | 9.44 | |||
| Expected Short fall | (2.88) | |||
| Skewness | 0.5539 | |||
| Kurtosis | 0.8366 |
Consider InspireMD's intraday indicators
InspireMD intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of InspireMD stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 754.82 | |||
| Daily Balance Of Power | 1.75 | |||
| Rate Of Daily Change | 1.06 | |||
| Day Median Price | 2.54 | |||
| Day Typical Price | 2.55 | |||
| Price Action Indicator | 0.1 | |||
| Period Momentum Indicator | 0.14 |
InspireMD Corporate Filings
F4 | 10th of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 12th of December 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 4th of December 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
F3 | 27th of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
InspireMD Stock media impact
Far too much social signal, news, headlines, and media speculation about InspireMD that are available to investors today. That information is available publicly through InspireMD media outlets and privately through word of mouth or via InspireMD internal channels. However, regardless of the origin, that massive amount of InspireMD data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of InspireMD news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of InspireMD relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to InspireMD's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive InspireMD alpha.
InspireMD Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards InspireMD can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
InspireMD Corporate Management
| Shane Gleason | Chief Officer | Profile | |
| Roei Samuri | VP Operations | Profile | |
| DVM MD | Executive Affairs | Profile | |
| Andrea Tommasoli | Chief Officer | Profile | |
| Amir Kohen | Vice Resources | Profile |
Additional Tools for InspireMD Stock Analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.